Associate Professor of Medicine, HMS
Asthma Epidemiology & Therapeutics
Therapeutic advances can revolutionize the care of individuals with severe asthma and other allergic diseases. However, most of the evidence on the efficacy of therapeutics, including monoclonal antibodies, comes from clinical trials with populations that may not represent the real world. My research focuses on the use of real-world data to answer questions on the effectiveness of monoclonal antibodies, heterogeneity of treatment effect, and predictors of response.